<?xml version="1.0" encoding="UTF-8"?>
<p>The need for rapid action to conduct clinical trial of an infectious disease outbreak will require expedited review of the study proposal by the ethics committee (EC), which will have limited information to evaluate riskâ€“benefit ratio of IP in participants who are vulnerable. The EC can review clinical research proposal during epidemic outbreaks through an expedited review or unscheduled full committee meetings.[
 <xref rid="ref9" ref-type="bibr">9</xref>] Hydroxychloroquine trial was approved by the French EC within 1 day of submission.[
 <xref rid="ref5" ref-type="bibr">5</xref>]
</p>
